← Open Payments lookup

KAROLYN WILDER: Open Payments

NPI 1518621994 · PETOSKEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,113 in 102 payments from 13 companies in 2025. Trend: 2023 $2,025 · 2024 $1,658 · 2025 $2,113

Food & beverage: $2,113
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.22$478
Neurocrine BioSciences, Inc.7$269
Axsome Therapeutics, Inc.12$258
ABBVIE INC.25$243
Lundbeck LLC10$218
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$148
E.R. Squibb & Sons, L.L.C.4$147
Janssen Pharmaceuticals, Inc5$142
Vanda Pharmaceuticals Inc.3$66
Takeda Pharmaceuticals U.S.A., Inc.3$59

Products named: REXULTI, INGREZZA, Auvelity, VRAYLAR, ABILIFY MAINTENA, CAPLYTA, COBENFY, INVEGA SUSTENNA.

Industry payments across MI — which companies pay providers there.